DRUG

NASDAQ Healthcare

Bright Minds Biosciences Inc. - common stock

Biotechnology

Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2 Receptors, which are serotonin agonists for epilepsy and neuropsychiatric disorders; and BMB-101, which has completed phase 1 trial for undisclosed seizure disorder and is in phase 2 clinical trials for the developmental and epileptic encephalopathies and absence epilepsies. The company also develops BMB-201 and BMB-202 for the treatment of neuropsychiatric and neurology indications; and BMB-105, a 5-HT2C agonist to treat Prader Willi Syndrome. Bright Minds Biosciences Inc. has a collaboration with Firefly Neuroscience, Inc. to provide an analysis of the electroencephalogram (EEG) data in the Company's BREAKTHROUGH study. The company was founded in 2017 and is headquartered in New York, New York.

๐Ÿ“Š Market Data
Price$86.96
Volume377,967
Market Cap851.09M
Beta-0.110
RSI (14-Day)54.4
200-Day MA$66.31
50-Day MA$80.78
52-Week High$123.75
52-Week Low$23.18
Forward P/E-11.18
Price / Book10.38
๐ŸŽฏ Investment Strategy Scores

DRUG scores across each investment strategy. Higher is better for that strategy's goals.

High dividend yield + low volatility
๐Ÿš€ Moon Shot 8/100โ–ฒ +3
High growth potential (high beta + oversold)
๐Ÿ”ช Falling Knife 24/100โ–ฒ +5
Contrarian plays (oversold + below moving average)
๐ŸŽˆ Over-Hyped 46/100โ–ผ -11
Overbought stocks (potential short candidates)
Large-cap, institutional-quality stocks
๐Ÿ” Strategy Interpretation

Best fit: ๐Ÿ’ฐ Dividend Daddy (50/100) โ€” this strategy High dividend yield + low volatility.

Lowest fit among scored strategies: ๐Ÿš€ Moon Shot (8/100). No single score is a buy or sell signal โ€” use multiple lenses together. Learn how to read these scores โ†’

Find DRUG in your text

Paste any article, transcript, or post โ€” the tool will extract DRUG and every other hidden ticker.

Try the Ticker Extractor โ†’

Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-05-01.